XML 67 R57.htm IDEA: XBRL DOCUMENT v3.22.2.2
Equity - Stock Option Activity (Details)
$ / shares in Units, shares in Thousands, $ in Thousands
 6 Months Ended 12 Months Ended
Sep. 30, 2022
USD ($)
$ / shares
shares
Mar. 31, 2022
USD ($)
$ / shares
shares
Number of Shares (in thousands)    
Beginning balance (in shares) | shares 26,983  
Options exercised (in shares) | shares (1,787)  
Options forfeited or expired (in shares) | shares (407)  
Ending balance (in shares) | shares 24,789 26,983
Vested and exercisable, at end of period (in shares) | shares 11,186  
Vested and expected to vest, at end of period (in shares) | shares 23,204  
Weighted-Average Exercise Price    
Beginning balance (in dollars per share) | $ / shares $ 4.15  
Exercised (in dollars per share) | $ / shares 3.09  
Forfeited or expired (in dollars per share) | $ / shares 5.78  
Ending balance (in dollars per share) | $ / shares 4.20 $ 4.15
Weighted average exercise price, vested and exercisable at period end (in dollars per share) | $ / shares 2.12  
Weighted average exercise price, vested and expected to vest at period end (in dollars per share) | $ / shares $ 4.11  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]    
Average remaining contractual term, outstanding 7 years 2 months 1 day 7 years 7 months 17 days
Average remaining contractual term, vested and exercisable at period end 6 years 18 days  
Average remaining contractual term, vested and expected to vest at period end 7 years 1 month 9 days  
Aggregate intrinsic value, outstanding | $ $ 644,960 $ 1,293,545
Aggregate intrinsic value, vested and exercisable at period end | $ 314,388  
Aggregate intrinsic value, vested and expected to vest at period end | $ $ 605,967